These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1128771)

  • 41. [Use of Magnesium compositum in arteriosclerosis of the vessels of the heart, brain and lower extremities].
    Savenkov PM; Martynov AI; Kertsman GI; Bobrovskaia OB; Pogorel'skiĭ AI
    Kardiologiia; 1971 Oct; 11(10):85-91. PubMed ID: 5138051
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results of treatment of migraine patients with cinnarizine and flunarizine].
    Drillisch C; Girke W
    Med Welt; 1980 Dec; 31(51-52):1870-2. PubMed ID: 6110158
    [No Abstract]   [Full Text] [Related]  

  • 43. [Place of combined cinnarizine-heptanol acefyllinate in treatment of vertigo and ear buzzing of vascular origin].
    Calvet J; Coll J; Stefani JM
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Feb; 18(2):127-30. PubMed ID: 4392741
    [No Abstract]   [Full Text] [Related]  

  • 44. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
    Arrigo A; Lottici P; Alfonsi E; Terraneo GB
    Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic experience with Stugeron.
    Abrányi I
    Ther Hung; 1973; 21(3-4):117-20. PubMed ID: 4806419
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of recordil-30 in arteriosclerosis of the arteries of the heart, brain and lower extremities].
    Zadionchenko VS; Savenkov PM; Martynov AI
    Kardiologiia; 1974 Apr; 14(4):108-12. PubMed ID: 4836803
    [No Abstract]   [Full Text] [Related]  

  • 47. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 48. [Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency].
    Stroganova IM; Kiparisov MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):70-2. PubMed ID: 20443242
    [No Abstract]   [Full Text] [Related]  

  • 49. [Intermittent claudication. Attempt at an objective vue of the disease and the possible treatment results with Sibelium].
    Loots W; Dom J; Hörig C
    Med Welt; 1980 Feb; 31(5):189-92. PubMed ID: 7366398
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative evaluation of the therapeutic effectiveness of drugs of different mechanisms of action in cerebral atherosclerosis].
    Sobczyk W
    Neurol Neurochir Pol; 1982; 16(4):245-60. PubMed ID: 7145012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].
    Wörz R; Drillisch C
    MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411
    [No Abstract]   [Full Text] [Related]  

  • 52. Preliminary results in the treatment of the unstable bladder with Flunarizine.
    Tosto A; Rinnovati A; Rizzo M
    Acta Urol Belg; 1983; 51(3):300-3. PubMed ID: 6624619
    [No Abstract]   [Full Text] [Related]  

  • 53. [Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo)].
    Perelló E; Esteller E; Colls A; Magriñá C; Massegur H; Lluansí J; Casamitjana JF; Lao X; Roca-Ribas F; Miró N; Prades J; Herrero E; Molá O; Torres J; Márquez M; Ortiz JA
    An Otorrinolaringol Ibero Am; 1998; 25(3):291-310. PubMed ID: 9658668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of flunarizine in the prophylaxis of migraine.
    Centonze V; Tesauro P; Trizio T; Magrone D; Vino M; Macinagrossa G; Campanozzi F; Altomare E; Attolini E; Albano O
    Cephalalgia; 1985 May; 5 Suppl 2():165-8. PubMed ID: 3893737
    [No Abstract]   [Full Text] [Related]  

  • 55. [Behavior of the thromboelastogram (TEG) in arteriosclerotic subjects treated with natural mucopolysaccharide substances].
    Garbagnati N; Iaschi P; Ciavarelli F; Carignola W
    Clin Ter; 1969 Jul; 50(2):125-31. PubMed ID: 4243098
    [No Abstract]   [Full Text] [Related]  

  • 56. Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle capacity, and vascular tone.
    Schuermans V; Boermans A; Geivers H; Jageneau A; Brugmans J
    Arzneimittelforschung; 1971 Oct; 21(10):1541-3. PubMed ID: 5171882
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of atherosclerosis with cobalt-containing preparations].
    Khodzhaev AKh; Ashirmatov AE; Mirochnik LM
    Klin Med (Mosk); 1972 Jan; 50(1):77-82. PubMed ID: 5020034
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 60. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
    Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
    Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.